Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-02-11

Clinical Trial Update: Single Dose Ciprofloxacin in the Treatment of Childhood Cholera:Randomized Controlled Clinical Trial [Phase 3]

View source ↗

Summary

A Phase 3 randomized controlled trial evaluating single-dose ciprofloxacin for treating childhood cholera has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ciprofloxacin (Ciprofloxacin hydrochloride)

Snippet

Sponsor: International Centre for Diarrhoeal Disease Research, Bangladesh | Conditions: Cholera | Phase 3 | Status: COMPLETED